Kinyoun James L
Department of Ophthalmology, University of Washington, Seattle, Washington, USA.
Trans Am Ophthalmol Soc. 2008;106:325-35.
To report ocular findings in eyes with radiation retinopathy and visual acuity (VA) results of photocoagulation for macular edema and proliferative retinopathy.
This retrospective case series compared VA after photocoagulation treatment and nontreatment of radiation macular edema. Visual outcomes were assessed with regression analyses.
Eighty-seven eyes (78 [89.7%] treated with external beam irradiation and 9 treated with local plaques) were studied. Fifty-nine (67.8%) and 28 (32.2%) eyes had nonproliferative and proliferative retinopathy, respectively; macular edema developed in 42 nonproliferative eyes (71.2%) and 24 proliferative eyes (85.7%). Initial VAs (median) were 20/40 and 20/65 for nonproliferative and proliferative eyes, respectively, and final VA was 20/80 and 20/400. Initial VA (median) in eyes with macular edema was 20/50 compared to 20/25 in eyes without edema; final VAs were 20/200 and 20/30. Comparing treated (19 [45.2%]) and untreated (23[54.8%]) macular edema in 42 eyes with nonproliferative retinopathy, initial median VA (20/40 and 20/50) and final VA (20/100 and 20/200) were better in treated eyes. Regression analysis showed significant treatment effect (P = .003) when initial VA (logMAR) and months of follow-up were kept constant; treated eyes had mean final VA (logMAR) 0.36 (95% CI, 0.12-0.60) better than untreated eyes.
The presence of macular edema and proliferation indicates more severe retinopathy and worse visual prognosis than for eyes without macular edema and proliferation. Although these VA results suggest macular photocoagulation is beneficial, eyes with macular edema continue to lose vision despite treatment. Better prevention and treatment methods are needed for radiation retinopathy.
报告放射性视网膜病变患者的眼部检查结果,以及黄斑水肿和增殖性视网膜病变的光凝治疗视力(VA)结果。
本回顾性病例系列比较了光凝治疗和未治疗放射性黄斑水肿后的视力。通过回归分析评估视觉结果。
共研究了87只眼(78只[89.7%]接受外照射治疗,9只接受局部敷贴治疗)。59只眼(67.8%)为非增殖性视网膜病变,28只眼(32.2%)为增殖性视网膜病变;42只非增殖性眼(71.2%)和24只增殖性眼(85.7%)出现黄斑水肿。非增殖性和增殖性眼的初始视力(中位数)分别为20/40和20/65,最终视力分别为20/80和20/400。有黄斑水肿的眼初始视力(中位数)为20/50,无水肿的眼为20/25;最终视力分别为20/200和20/30。比较42只非增殖性视网膜病变眼中接受治疗(19只[45.2%])和未接受治疗(23只[54.8%])的黄斑水肿,接受治疗的眼初始中位数视力(20/40和20/50)和最终视力(20/100和20/200)更好。回归分析显示,当初始视力(logMAR)和随访月数保持不变时,治疗效果显著(P = .003);接受治疗的眼最终平均视力(logMAR)比未治疗的眼好0.36(95%CI,0.12 - 0.60)。
与无黄斑水肿和增殖的眼相比,黄斑水肿和增殖的存在表明视网膜病变更严重,视觉预后更差。尽管这些视力结果表明黄斑光凝有益,但黄斑水肿的眼尽管接受了治疗仍继续丧失视力。放射性视网膜病变需要更好的预防和治疗方法。